loadpatents
name:-0.045025825500488
name:-0.046637058258057
name:-0.00060486793518066
Murcko; Mark A. Patent Filings

Murcko; Mark A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Murcko; Mark A..The latest application filed is for "inhibitors of serine proteases, particularly hepatitis c virus ns3 protease".

Company Profile
0.35.28
  • Murcko; Mark A. - Holliston MA US
  • Murcko; Mark A - Holliston MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors of caspases
Grant 8,691,848 - Wannamaker , et al. April 8, 2
2014-04-08
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20130012430 - Tung; Roger D. ;   et al.
2013-01-10
Inhibitors of P38
Grant 8,338,412 - Bemis , et al. December 25, 2
2012-12-25
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 8,314,141 - Tung , et al. November 20, 2
2012-11-20
Inhibitors Of Interleukin-1 Beta Converting Enzyme
App 20120238749 - Bemis; Guy W. ;   et al.
2012-09-20
Inhibitors Of Interleukin-1 Beta Converting Enzyme
App 20120165319 - Batchelor; Mark James ;   et al.
2012-06-28
Inhibitors of interleukin-1.beta. converting enzyme
Grant 8,119,631 - Batchelor , et al. February 21, 2
2012-02-21
Inhibitors Of Interleukin-1 Beta Converting Enzyme
App 20110178069 - Batchelor; Mark James ;   et al.
2011-07-21
Inhibitors of p38
Grant 7,951,809 - Bemis , et al. May 31, 2
2011-05-31
Inhibitors of interleukin-1 beta converting enzyme
App 20110015371 - Bemis; Guy W. ;   et al.
2011-01-20
Inhibitors of interleukin-1.beta. converting enzyme
Grant 7,790,713 - Batchelor , et al. September 7, 2
2010-09-07
Novel Sulfonamide Inhibitors Of Aspartyl Protease
App 20100210603 - Tung; Roger D. ;   et al.
2010-08-19
Inhibitors of interleukin-1.beta. converting enzyme
Grant 7,772,366 - Bemis , et al. August 10, 2
2010-08-10
Inhibitors Of Serine Proteases, Particularly Hcv Ns3-ns4a Protease
App 20100173851 - Pitlik; Janos ;   et al.
2010-07-08
Sulfonamide inhibitors of aspartyl protease
Grant 7,608,632 - Tung , et al. October 27, 2
2009-10-27
INHIBITORS OF p38
App 20090203702 - Bemis; Guy W. ;   et al.
2009-08-13
Inhibitors Of Serine Proteases, Particularly Hepatitis C Virus Ns3 Protease
App 20090143312 - Tung; Roger D. ;   et al.
2009-06-04
Inhibitors of caspases
App 20090048226 - Wannamaker; Marion W. ;   et al.
2009-02-19
Novel sulfonamide inhibitors of aspartyl protease
App 20080293727 - Tung; Roger D. ;   et al.
2008-11-27
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 7,388,017 - Tung , et al. June 17, 2
2008-06-17
Inhibitors of p38
Grant 7,365,072 - Bemis , et al. April 29, 2
2008-04-29
Inhibitors of caspases
Grant 7,358,273 - Wannamaker , et al. April 15, 2
2008-04-15
Inhibitors of interleukin-1 beta converting enzyme
App 20080070953 - Bemis; Guy W. ;   et al.
2008-03-20
Inhibitors of interleukin-1beta converting enzyme
App 20080039449 - Batchelor; Mark James ;   et al.
2008-02-14
Sulfonamide inhibitors of aspartyl protease
Grant 7,321,063 - Tung , et al. January 22, 2
2008-01-22
Inhibitors of serine proteases, particular HCV NS3-NS4A protease
App 20070292933 - Pitlik; Janos ;   et al.
2007-12-20
Inhibitors of interleukin-1.beta. converting enzyme
Grant 7,288,624 - Bemis , et al. October 30, 2
2007-10-30
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
Grant 7,273,885 - Pitlik , et al. September 25, 2
2007-09-25
Inhibitors of p38
Grant 7,205,305 - Bemis , et al. April 17, 2
2007-04-17
Novel sulfonamide inhibitors of aspartyl protease
App 20060189810 - Tung; Roger D. ;   et al.
2006-08-24
Inhibitors of interleukin 1-.beta. converting enzyme
Grant 6,974,809 - Golec , et al. December 13, 2
2005-12-13
Inhibitors of interleukin-1beta converting enzyme
App 20050143436 - Batchelor, Mark James ;   et al.
2005-06-30
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20040266731 - Tung, Roger D. ;   et al.
2004-12-30
Novel sulfonamide inhibitors of aspartyl protease
App 20040167116 - Tung, Roger D. ;   et al.
2004-08-26
Sulfonamide inhibitors of aspartyl protease
Grant 6,720,335 - Tung , et al. April 13, 2
2004-04-13
Inhibitors of interleukin 1-beta converting enzyme
App 20040048855 - Golec, Julian M .C. ;   et al.
2004-03-11
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
App 20040018986 - Pitlik, Janos ;   et al.
2004-01-29
Inhibitors of caspases
App 20030232986 - Wannamaker, Marion M. ;   et al.
2003-12-18
Inhibitors of interleukin-1beta converting enzyme
App 20030225269 - Batchelor, Mark James ;   et al.
2003-12-04
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,617,309 - Tung , et al. September 9, 2
2003-09-09
Inhibitors of bace
App 20030095958 - Bhisetti, Govinda R. ;   et al.
2003-05-22
Inhibitors of interleukin-1beta converting enzyme
App 20030069228 - Golec, Julian M.C. ;   et al.
2003-04-10
Novel sulfonamide inhibitors of aspartyl protease
App 20030069222 - Tung, Roger D. ;   et al.
2003-04-10
Novel sulfonamide inhibitors of aspartyl protease
App 20030064977 - Tung, Roger D. ;   et al.
2003-04-03
Inhibitors of interleukin-1 beta converting enzyme
App 20020099042 - Bemis, Guy W. ;   et al.
2002-07-25
Inhibitors of interleukin-1.beta. converting enzyme
Grant 6,423,840 - Batchelor , et al. July 23, 2
2002-07-23
Inhibitors of interleukin-1.beta. converting enzyme
Grant 6,420,522 - Bemis , et al. July 16, 2
2002-07-16
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
App 20020032175 - Tung, Roger D. ;   et al.
2002-03-14
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
Grant 6,265,380 - Tung , et al. July 24, 2
2001-07-24
Inhibitors of Interleukin-1.beta. converting enzyme
Grant 6,258,948 - Batchelor , et al. July 10, 2
2001-07-10
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors
Grant 6,204,261 - Batchelor , et al. March 20, 2
2001-03-20
Inhibitors of interleukin-1.beta. converting enzyme
Grant 6,103,711 - Bemis , et al. August 15, 2
2000-08-15
Inhibitors of interleukin-1 .beta. converting enzyme
Grant 6,025,147 - Bemis , et al. February 15, 2
2000-02-15
Inhibitors of interleukin-1.beta. converting enzyme
Grant 6,008,217 - Batchelor , et al. December 28, 1
1999-12-28
Sulfonamide inhibitors of aspartyl protease
Grant 5,977,137 - Tung , et al. November 2, 1
1999-11-02
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,973,111 - Bemis , et al. October 26, 1
1999-10-26
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,874,424 - Batchelor , et al. February 23, 1
1999-02-23
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,847,135 - Bemis , et al. December 8, 1
1998-12-08
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,756,466 - Bemis , et al. May 26, 1
1998-05-26
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,716,929 - Bemis , et al. February 10, 1
1998-02-10
Inhibitors of interleukin-1.beta. converting enzyme
Grant 5,656,627 - Bemis , et al. August 12, 1
1997-08-12
Sulfonamide inhibitors of aspartyl protease
Grant 5,585,397 - Tung , et al. December 17, 1
1996-12-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed